<DOC>
	<DOCNO>NCT02408029</DOCNO>
	<brief_summary>This study perform obtain data CORA System use trauma clinical setting . The CORA analyzer new device currently test trauma clinical application yet clear purpose Food Drug Administration ( FDA ) sale United States .</brief_summary>
	<brief_title>Trauma Equivalency Study CORA® TEG® 5000 Systems</brief_title>
	<detailed_description>The purpose study validate CORA System compare result test standard care device call TEG 5000 system . Both system evaluate hemostasis , highly complex interactive process involve many protein cellular element , especially platelet , occur series interrelate phase , result either normal hemostasis tendency toward bleed clot complication . The study protocol specifies test use multiple reagent similar CORA TG 5000 system . Tests run duplicate blood sample take patient undergoing treatment injury trauma . Following protocol define CLSI Standard EP09-A2 , equivalence two system demonstrate conclusion Standard Section 7 , Interpreting Results Comparing Internal Performance Criteria , find acceptable . All blood sample draw study use venous blood . Only citrate heparinized whole blood sample use . All sample test twice ( run duplicate ) . Quality Control procedures run instrument frequency specify manufacturer . Results obtain test use make treatment decision .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>18 year age old Complete patient history include age , race , gender type trauma document Patients age 18 Native whole blood use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Focus</keyword>
	<keyword>Testing Performance</keyword>
	<keyword>CORA Hemostasis System</keyword>
</DOC>